Table 1.
Characteristic | Number (%) |
---|---|
Age | |
<40 years | 5 (4.5) |
40-50 years | 12 (10.8) |
51-60 years | 39 (35.2) |
61-70 years | 33 (29.7) |
>71 years | 22 (19.8) |
Karnofsky performance status | |
90-100% | 45 (44.6) |
70-80% | 51 (45.9) |
<70% | 5 (4.5) |
GPA | |
0 | 0 (0.0) |
0.5 | 2 (1.8) |
1.0 | 14 (12.6) |
1.5 | 11 (9.9) |
2.0 | 21 (18.9) |
2.5 | 17 (15.3) |
3.0 | 19 (17.1) |
3.5 | 4 (3.6) |
4.0 | 6 (5.4) |
Unknown | 16 (14.4) |
RPA | |
I | 22 (19.8) |
II | 74 (66.7) |
III | 3 (2.7) |
Unknown | 12 (10.8) |
Primary histology | |
Non–small cell lung | 49 (44.2) |
Melanoma | 24 (39.6) |
Breast | 18 (16.2) |
Small-cell lung | 3 (2.7) |
Other | 17 (15.3) |
Extracranial disease | |
Controlled | 46 (41.4) |
Uncontrolled | 65 (58.6) |
Abbreviations: GPA, graded prognostic assessment; RPA, recursive partition analysis.
aN = 111.
bKarnofsky performance status (KPS) does not equal 100% and 10 patients did not have known KPS.